Forte Biosciences Inc. buy krebskrebs
Start price
04.10.21
/
50%
€2.60
Target price
04.10.22
€5.00
Performance (%)
-58.69%
End price
05.10.22
€1.07
Summary
This prediction ended on 05.10.22 with a price of €1.07. Massive losses of -58.69% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Forte Biosciences Inc. | - | - | - | - |
| iShares Core DAX® | 3.593% | 3.931% | 15.378% | 53.202% |
| iShares Nasdaq 100 | 5.810% | 5.518% | 41.455% | 91.095% |
| iShares Nikkei 225® | 4.075% | 8.460% | 48.947% | 63.933% |
| iShares S&P 500 | 4.142% | 4.039% | 31.594% | 64.840% |
Comments by krebskrebs for this prediction
In the thread Tocagen diskutieren
In the thread Trading Tocagen
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten